Literature DB >> 11304471

Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo.

K Morishige1, H Shimokawa, Y Eto, T Kandabashi, K Miyata, Y Matsumoto, M Hoshijima, K Kaibuchi, A Takeshita.   

Abstract

Small GTPase Rho and its target Rho-kinase/ROK/ROCK play an important role in various cellular functions, including smooth muscle contraction, actin cytoskeleton organization, and cell adhesion and migration, all of which may be involved in the pathogenesis of arteriosclerosis. Here, we show that adenovirus-mediated transfer of dominant-negative Rho-kinase (DNRhoK) induces a marked regression of coronary constrictive remodeling and abolishes coronary vasospastic activity in vivo. Porcine coronary segments were chronically treated with interleukin-1beta, which resulted in the development of constrictive remodeling and vasospastic responses to serotonin, as previously reported. Adenovirus-mediated transfer of DNRhoK, but not that of beta-galactosidase, into the interleukin-1beta-treated coronary segment caused a marked regression of the constrictive remodeling and abolished the vasospastic activity in 3 weeks. Western blot analysis showed that the phosphorylation of adducin and the ezrin/radixin/moesin family, the target proteins of Rho-kinase, were upregulated at the coronary lesions and were significantly suppressed by the transfer of DNRHOK: These results indicate that Rho-kinase is substantially involved in coronary constrictive remodeling and vasospastic responses, both of which can be reversed by the selective inhibition of the molecule in our porcine model in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304471     DOI: 10.1161/01.atv.21.4.548

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  19 in total

1.  Role of Rho kinase signalling in healthy and varicose human saphenous veins.

Authors:  Chrystelle Cario-Toumaniantz; Sandrine Evellin; Séverine Maury; Olivier Baron; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Direct effects of Rho-kinase inhibitor on pial microvessels in rabbits.

Authors:  Masakazu Kotoda; Tadahiko Ishiyama; Noriyuki Shintani; Takashi Matsukawa
Journal:  J Anesth       Date:  2014-08-24       Impact factor: 2.078

3.  The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.

Authors:  Raj Kishore; Gangjian Qin; Corinne Luedemann; Evelyn Bord; Allison Hanley; Marcy Silver; Mary Gavin; Young-sup Yoon; David Goukassian; David Goukassain; Douglas W Losordo
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

Review 4.  Signaling mechanisms that regulate smooth muscle cell differentiation.

Authors:  Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

Review 5.  ROCKs as therapeutic targets in cardiovascular diseases.

Authors:  Yoshiyuki Rikitake; James K Liao
Journal:  Expert Rev Cardiovasc Ther       Date:  2005-05

Review 6.  Angiotensin and cytoskeletal proteins: role in vascular remodeling.

Authors:  Jos P M Wesselman; Jo G R De Mey
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

7.  IL-1beta modulate the Ca(2+)-activated big-conductance K channels (BK) via reactive oxygen species in cultured rat aorta smooth muscle cells.

Authors:  Yuan Gao; Ying Yang; Qigang Guan; Xuefeng Pang; Haishan Zhang; Dingyin Zeng
Journal:  Mol Cell Biochem       Date:  2009-12-01       Impact factor: 3.396

Review 8.  The pericyte: cellular regulator of microvascular blood flow.

Authors:  Matthew E Kutcher; Ira M Herman
Journal:  Microvasc Res       Date:  2009-02-07       Impact factor: 3.514

9.  A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Authors:  Ming Dong; James K Liao; Bryan Yan; Ruijie Li; Mang Zhang; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2012-08-24       Impact factor: 4.164

10.  Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.

Authors:  Ming Dong; Xin Jiang; James K Liao; Bryan P Yan
Journal:  Clin Cardiol       Date:  2013-03-28       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.